APO Research
Talk to an analyst

APO RESEARCH · REPORT

TROP2-ADC Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global TROP2-ADC Drug Industry Growth and Trends Forecast to 2032

28 December 2025106 pages

Choose your research edition.

Industry ResearchTROP2-ADC Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal TROP2-ADC Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal TROP2-ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TROP2-ADC Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal TROP2-ADC Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global TROP2-ADC Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TROP2-ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of TROP2-ADC Drug include AstraZeneca, BiOneCure Therapeutics, Chiome Bioscience, Gilead, LegoChem Biosciences, Merck, Duoxi Biotech, Kelun Biotech and Shijian Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global TROP2-ADC Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The TROP2-ADC Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global TROP2-ADC Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to TROP2-ADC Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global TROP2-ADC Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

TROP2-ADC Drug Market by Company

AstraZeneca

BiOneCure Therapeutics

Chiome Bioscience

Gilead

LegoChem Biosciences

Merck

Duoxi Biotech

Kelun Biotech

Shijian Biotech

DualityBio

TROP2-ADC Drug Segment by Type

Clinical Drugs

Marketed Drugs

TROP2-ADC Drug Segment by Application

Hematological Tumors

Solid Tumors

TROP2-ADC Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TROP2-ADC Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TROP2-ADC Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TROP2-ADC Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of TROP2-ADC Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of TROP2-ADC Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Clinical Drugs Table 2. Major Company of Marketed Drugs Table 3. Global TROP2-ADC Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global TROP2-ADC Drug Sales by Type (2021-2026) & (K Units) Table 5. Global TROP2-ADC Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global TROP2-ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global TROP2-ADC Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global TROP2-ADC Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global TROP2-ADC Drug Sales by Type (2027-2032) & (K Units) Table 10. Global TROP2-ADC Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global TROP2-ADC Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global TROP2-ADC Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global TROP2-ADC Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America TROP2-ADC Drug Sales by Type (2021-2026) & (K Units) Table 15. North America TROP2-ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe TROP2-ADC Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe TROP2-ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific TROP2-ADC Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific TROP2-ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America TROP2-ADC Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America TROP2-ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa TROP2-ADC Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa TROP2-ADC Drug Sales by Type (2021-2026) & (US$ Million) Table 24. TROP2-ADC Drug Industry Trends Table 25. TROP2-ADC Drug Industry Drivers Table 26. TROP2-ADC Drug Industry Opportunities and Challenges Table 27. TROP2-ADC Drug Industry Restraints Table 28. Global TROP2-ADC Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global TROP2-ADC Drug Revenue Market Share by Company (2021-2026) Table 30. Global TROP2-ADC Drug Sales by Company (2021-2026) & (K Units) Table 31. Global TROP2-ADC Drug Sales Share by Company (2021-2026) Table 32. Global TROP2-ADC Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global TROP2-ADC Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global TROP2-ADC Drug Major Company Production Sites and Headquarters Table 35. Global TROP2-ADC Drug Company, Product Type & Application Table 36. Global TROP2-ADC Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global TROP2-ADC Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global TROP2-ADC Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global TROP2-ADC Drug Sales by Region (2021-2026) & (K Units) Table 41. Global TROP2-ADC Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global TROP2-ADC Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global TROP2-ADC Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global TROP2-ADC Drug Sales by Region (2027-2032) & (K Units) Table 46. Global TROP2-ADC Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global TROP2-ADC Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global TROP2-ADC Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global TROP2-ADC Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global TROP2-ADC Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global TROP2-ADC Drug Sales by Application (2021-2026) & (K Units) Table 52. Global TROP2-ADC Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global TROP2-ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global TROP2-ADC Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global TROP2-ADC Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global TROP2-ADC Drug Sales by Application (2027-2032) & (K Units) Table 57. Global TROP2-ADC Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global TROP2-ADC Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global TROP2-ADC Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global TROP2-ADC Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America TROP2-ADC Drug Sales by Application (2021-2026) & (K Units) Table 62. North America TROP2-ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe TROP2-ADC Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe TROP2-ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific TROP2-ADC Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific TROP2-ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America TROP2-ADC Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America TROP2-ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa TROP2-ADC Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa TROP2-ADC Drug Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZeneca TROP2-ADC Drug Product Portfolio Table 75. AstraZeneca Recent Development Table 76. BiOneCure Therapeutics Company Information Table 77. BiOneCure Therapeutics Business Overview Table 78. BiOneCure Therapeutics TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. BiOneCure Therapeutics TROP2-ADC Drug Product Portfolio Table 80. BiOneCure Therapeutics Recent Development Table 81. Chiome Bioscience Company Information Table 82. Chiome Bioscience Business Overview Table 83. Chiome Bioscience TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Chiome Bioscience TROP2-ADC Drug Product Portfolio Table 85. Chiome Bioscience Recent Development Table 86. Gilead Company Information Table 87. Gilead Business Overview Table 88. Gilead TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Gilead TROP2-ADC Drug Product Portfolio Table 90. Gilead Recent Development Table 91. LegoChem Biosciences Company Information Table 92. LegoChem Biosciences Business Overview Table 93. LegoChem Biosciences TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. LegoChem Biosciences TROP2-ADC Drug Product Portfolio Table 95. LegoChem Biosciences Recent Development Table 96. Merck Company Information Table 97. Merck Business Overview Table 98. Merck TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merck TROP2-ADC Drug Product Portfolio Table 100. Merck Recent Development Table 101. Duoxi Biotech Company Information Table 102. Duoxi Biotech Business Overview Table 103. Duoxi Biotech TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Duoxi Biotech TROP2-ADC Drug Product Portfolio Table 105. Duoxi Biotech Recent Development Table 106. Kelun Biotech Company Information Table 107. Kelun Biotech Business Overview Table 108. Kelun Biotech TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Kelun Biotech TROP2-ADC Drug Product Portfolio Table 110. Kelun Biotech Recent Development Table 111. Shijian Biotech Company Information Table 112. Shijian Biotech Business Overview Table 113. Shijian Biotech TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shijian Biotech TROP2-ADC Drug Product Portfolio Table 115. Shijian Biotech Recent Development Table 116. DualityBio Company Information Table 117. DualityBio Business Overview Table 118. DualityBio TROP2-ADC Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. DualityBio TROP2-ADC Drug Product Portfolio Table 120. DualityBio Recent Development Table 121. North America TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 123. North America TROP2-ADC Drug Sales Market Share by Country (2021-2026) Table 124. North America TROP2-ADC Drug Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America TROP2-ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 126. North America TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America TROP2-ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. North America TROP2-ADC Drug Market Share by Country (2021-2026) Table 129. North America TROP2-ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America TROP2-ADC Drug Market Share Forecast by Country (2027-2032) Table 131. Europe TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 133. Europe TROP2-ADC Drug Sales Market Share by Country (2021-2026) Table 134. Europe TROP2-ADC Drug Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe TROP2-ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Europe TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe TROP2-ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe TROP2-ADC Drug Market Share by Country (2021-2026) Table 139. Europe TROP2-ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe TROP2-ADC Drug Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific TROP2-ADC Drug Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific TROP2-ADC Drug Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific TROP2-ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific TROP2-ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific TROP2-ADC Drug Market Share by Country (2021-2026) Table 149. Asia-Pacific TROP2-ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific TROP2-ADC Drug Market Share Forecast by Country (2027-2032) Table 151. Latin America TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 153. Latin America TROP2-ADC Drug Sales Market Share by Country (2021-2026) Table 154. Latin America TROP2-ADC Drug Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America TROP2-ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America TROP2-ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America TROP2-ADC Drug Market Share by Country (2021-2026) Table 159. Latin America TROP2-ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America TROP2-ADC Drug Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa TROP2-ADC Drug Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa TROP2-ADC Drug Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa TROP2-ADC Drug Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa TROP2-ADC Drug Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa TROP2-ADC Drug Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa TROP2-ADC Drug Market Share by Country (2021-2026) Table 169. Middle East and Africa TROP2-ADC Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa TROP2-ADC Drug Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. TROP2-ADC Drug Distributors List Table 174. TROP2-ADC Drug Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. TROP2-ADC Drug Image Figure 2. Global TROP2-ADC Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TROP2-ADC Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global TROP2-ADC Drug Sales (2021-2032) & (K Units) Figure 5. Clinical Drugs Image Figure 6. Global Clinical Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Marketed Drugs Image Figure 8. Global Marketed Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global TROP2-ADC Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global TROP2-ADC Drug Market Share by Type 2025 VS 2032 Figure 11. North America TROP2-ADC Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America TROP2-ADC Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe TROP2-ADC Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe TROP2-ADC Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific TROP2-ADC Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific TROP2-ADC Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America TROP2-ADC Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America TROP2-ADC Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa TROP2-ADC Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa TROP2-ADC Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 TROP2-ADC Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hematological Tumors Image Figure 24. Global Hematological Tumors Sales YoY Growth (2021-2032) & (K Units) Figure 25. Solid Tumors Image Figure 26. Global Solid Tumors Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global TROP2-ADC Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global TROP2-ADC Drug Market Share by Application 2025 VS 2032 Figure 29. North America TROP2-ADC Drug Sales Market Share in Volume by Application in 2025 Figure 30. North America TROP2-ADC Drug Sales Market Share in Value by Application in 2025 Figure 31. Europe TROP2-ADC Drug Sales Market Share in Volume by Application in 2025 Figure 32. Europe TROP2-ADC Drug Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific TROP2-ADC Drug Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific TROP2-ADC Drug Sales Market Share in Value by Application in 2025 Figure 35. Latin America TROP2-ADC Drug Sales Market Share in Volume by Application in 2025 Figure 36. Latin America TROP2-ADC Drug Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa TROP2-ADC Drug Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa TROP2-ADC Drug Sales Market Share in Value by Application in 2025 Figure 39. North America TROP2-ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America TROP2-ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America TROP2-ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America TROP2-ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe TROP2-ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe TROP2-ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe TROP2-ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe TROP2-ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific TROP2-ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific TROP2-ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific TROP2-ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific TROP2-ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America TROP2-ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America TROP2-ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America TROP2-ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America TROP2-ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa TROP2-ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa TROP2-ADC Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa TROP2-ADC Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa TROP2-ADC Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. TROP2-ADC Drug Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. TROP2-ADC Drug Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical Drugs
  • Marketed Drugs
Applications
  • Hematological Tumors
  • Solid Tumors
Companies covered
  • AstraZeneca
  • BiOneCure Therapeutics
  • Chiome Bioscience
  • Gilead
  • LegoChem Biosciences
  • Merck
  • Duoxi Biotech
  • Kelun Biotech
  • Shijian Biotech
  • DualityBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global TROP2-ADC Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global TROP2-ADC Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 TROP2-ADC Drug Market by Type
  6. 1.3.1 Clinical Drugs
  7. 1.3.2 Marketed Drugs
  8. 1.4 Global TROP2-ADC Drug Market Size by Type
  9. 1.4.1 Global TROP2-ADC Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global TROP2-ADC Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global TROP2-ADC Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America TROP2-ADC Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe TROP2-ADC Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific TROP2-ADC Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America TROP2-ADC Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa TROP2-ADC Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 TROP2-ADC Drug Industry Trends
  2. 2.2 TROP2-ADC Drug Industry Drivers
  3. 2.3 TROP2-ADC Drug Industry Opportunities and Challenges
  4. 2.4 TROP2-ADC Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by TROP2-ADC Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by TROP2-ADC Drug Sales (2021-2026)
  3. 3.3 Global Top Players by TROP2-ADC Drug Price (2021-2026)
  4. 3.4 Global TROP2-ADC Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global TROP2-ADC Drug Major Company Production Sites & Headquarters
  6. 3.6 Global TROP2-ADC Drug Company, Product Type & Application
  7. 3.7 Global TROP2-ADC Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global TROP2-ADC Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 TROP2-ADC Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 TROP2-ADC Drug Tier 1, Tier 2, and Tier 3
4 TROP2-ADC Drug Regional Status and Outlook
  1. 4.1 Global TROP2-ADC Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global TROP2-ADC Drug Historic Market Size by Region
  3. 4.2.1 Global TROP2-ADC Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global TROP2-ADC Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global TROP2-ADC Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global TROP2-ADC Drug Forecasted Market Size by Region
  7. 4.3.1 Global TROP2-ADC Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global TROP2-ADC Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global TROP2-ADC Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 TROP2-ADC Drug by Application
  1. 5.1 TROP2-ADC Drug Market by Application
  2. 5.1.1 Hematological Tumors
  3. 5.1.2 Solid Tumors
  4. 5.2 Global TROP2-ADC Drug Market Size by Application
  5. 5.2.1 Global TROP2-ADC Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global TROP2-ADC Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global TROP2-ADC Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America TROP2-ADC Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe TROP2-ADC Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific TROP2-ADC Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America TROP2-ADC Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa TROP2-ADC Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca TROP2-ADC Drug Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 BiOneCure Therapeutics
  8. 6.2.1 BiOneCure Therapeutics Company Information
  9. 6.2.2 BiOneCure Therapeutics Business Overview
  10. 6.2.3 BiOneCure Therapeutics TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BiOneCure Therapeutics TROP2-ADC Drug Product Portfolio
  12. 6.2.5 BiOneCure Therapeutics Recent Developments
  13. 6.3 Chiome Bioscience
  14. 6.3.1 Chiome Bioscience Company Information
  15. 6.3.2 Chiome Bioscience Business Overview
  16. 6.3.3 Chiome Bioscience TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chiome Bioscience TROP2-ADC Drug Product Portfolio
  18. 6.3.5 Chiome Bioscience Recent Developments
  19. 6.4 Gilead
  20. 6.4.1 Gilead Company Information
  21. 6.4.2 Gilead Business Overview
  22. 6.4.3 Gilead TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gilead TROP2-ADC Drug Product Portfolio
  24. 6.4.5 Gilead Recent Developments
  25. 6.5 LegoChem Biosciences
  26. 6.5.1 LegoChem Biosciences Company Information
  27. 6.5.2 LegoChem Biosciences Business Overview
  28. 6.5.3 LegoChem Biosciences TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 LegoChem Biosciences TROP2-ADC Drug Product Portfolio
  30. 6.5.5 LegoChem Biosciences Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck TROP2-ADC Drug Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Duoxi Biotech
  38. 6.7.1 Duoxi Biotech Company Information
  39. 6.7.2 Duoxi Biotech Business Overview
  40. 6.7.3 Duoxi Biotech TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Duoxi Biotech TROP2-ADC Drug Product Portfolio
  42. 6.7.5 Duoxi Biotech Recent Developments
  43. 6.8 Kelun Biotech
  44. 6.8.1 Kelun Biotech Company Information
  45. 6.8.2 Kelun Biotech Business Overview
  46. 6.8.3 Kelun Biotech TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kelun Biotech TROP2-ADC Drug Product Portfolio
  48. 6.8.5 Kelun Biotech Recent Developments
  49. 6.9 Shijian Biotech
  50. 6.9.1 Shijian Biotech Company Information
  51. 6.9.2 Shijian Biotech Business Overview
  52. 6.9.3 Shijian Biotech TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shijian Biotech TROP2-ADC Drug Product Portfolio
  54. 6.9.5 Shijian Biotech Recent Developments
  55. 6.10 DualityBio
  56. 6.10.1 DualityBio Company Information
  57. 6.10.2 DualityBio Business Overview
  58. 6.10.3 DualityBio TROP2-ADC Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 DualityBio TROP2-ADC Drug Product Portfolio
  60. 6.10.5 DualityBio Recent Developments
7 North America by Country
  1. 7.1 North America TROP2-ADC Drug Sales by Country
  2. 7.1.1 North America TROP2-ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America TROP2-ADC Drug Sales by Country (2021-2026)
  4. 7.1.3 North America TROP2-ADC Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America TROP2-ADC Drug Market Size by Country
  6. 7.2.1 North America TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America TROP2-ADC Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America TROP2-ADC Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe TROP2-ADC Drug Sales by Country
  2. 8.1.1 Europe TROP2-ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe TROP2-ADC Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe TROP2-ADC Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe TROP2-ADC Drug Market Size by Country
  6. 8.2.1 Europe TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe TROP2-ADC Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe TROP2-ADC Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific TROP2-ADC Drug Sales by Country
  2. 9.1.1 Asia-Pacific TROP2-ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific TROP2-ADC Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific TROP2-ADC Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific TROP2-ADC Drug Market Size by Country
  6. 9.2.1 Asia-Pacific TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific TROP2-ADC Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific TROP2-ADC Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America TROP2-ADC Drug Sales by Country
  2. 10.1.1 South America TROP2-ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America TROP2-ADC Drug Sales by Country (2021-2026)
  4. 10.1.3 South America TROP2-ADC Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America TROP2-ADC Drug Market Size by Country
  6. 10.2.1 South America TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America TROP2-ADC Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America TROP2-ADC Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa TROP2-ADC Drug Sales by Country
  2. 11.1.1 Middle East and Africa TROP2-ADC Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa TROP2-ADC Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa TROP2-ADC Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa TROP2-ADC Drug Market Size by Country
  6. 11.2.1 Middle East and Africa TROP2-ADC Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa TROP2-ADC Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa TROP2-ADC Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 TROP2-ADC Drug Value Chain Analysis
  2. 12.1.1 TROP2-ADC Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 TROP2-ADC Drug Production Mode & Process
  7. 12.2 TROP2-ADC Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 TROP2-ADC Drug Distributors
  10. 12.2.3 TROP2-ADC Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst